After weathering a brutal stretch that saw her flagship ARK Innovation ETF (ARKK) lose nearly 80% of its value from its 2021 ...

Disruptive innovation investor Cathie Wood recently invested in clinical-stage biotech company Intellia Therapeutics (NTLA).

Cathie Wood, the CEO and chief investment officer of ARK Investment Management, has established a reputation thanks to ...

Explore Cathie Wood's investment strategy at Ark Invest. Discover her top stock picks like Tesla and CRISPR, and her focus on ...

Cathie Wood’s ARK Invest ETFs (exchange-traded funds) executed a series of trades on Friday, August 22, 2025, according to ...

Cathie Wood is most known for her bold, tech-first investing. She was an outlier during the 2021 boom as her aggressive bets ...

In latest Bitcoin news, BlackRock and Ark Invest sell over 1,000 BTC combined, as veteran traders warn of a potential price ...

Cathie Wood's ARK Innovation ETF is outperforming tech market again in 2025, driven by AI breakthroughs and the return of ...

Cathie Wood’s ARK Invest buys 356K Bullish (BLSH) shares despite a 32% drop. The stock still trades above its IPO price of $37.

Cathie Wood looks for growth and companies on their way to big profits. Warren Buffett prefers looking for value and consistent profits. The two investors have two stock investments in common.

On the buying side, ARK showed a strong conviction in PAGERDUTY INC (NYSE: PD ), purchasing 119,163 shares through its ARKK ETF, amounting to $1,918,524. This investment suggests a bullish outlook on ...

ARK also increased its position in CRISPR Therapeutics AG (NASDAQ: CRSP ), acquiring 176,811 shares worth $10,560,921. This trade aligns with ARK’s high conviction in gene-editing technologies, which ...